Sunday 24 June 2018
Contact US    |    Archive
Reuters
4 months ago

U.S. FDA approves AstraZeneca s immunotherapy for lung cancer

Feb 16 (Reuters) - The U.S. Food and Drug Administration on Friday granted approval for expanded use of AstraZeneca Plc s , immunotherapy drug, Imfinzi, to treat non-small cell lung cancer whose tumors can t be surgically removed.

Read on the original site


هذه الصفحة هي مجرد قاریء تلقائي للأخبار باستخدام خدمة الـ RSS و بأن نشر هذه الأخبار هنا لاتعني تأییدها علی الإطلاق.
Hashtags:   

FDA

 | 

approves

 | 

AstraZeneca

 | 

immunotherapy

 | 

for

 | 

lung

 | 

cancer

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Categories - Countries
All News
USA